P53与铁亡一起:一个有前途的策略,让癌细胞无法逃脱
Jianhao Zhan1,2, Jisheng Wang1, Yuqing Liang3
1Department of General Surgery, Second Affiliated Hospital of Nanchang University, Nanchang 330006, China.
Acta biochimica et biophysica Sinica
|December 18, 2023
概括
瘤抑制蛋白p53调节铁亡,这是一种细胞死亡途径,对于抑制癌症至关重要. 这项研究详细介绍了p53的情况.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 细胞死亡研究 细胞死亡研究
背景情况:
- TP53基因编码了p53蛋白,这是基因组稳定的关键调节剂,也是瘤形成的关键抑制剂.
- 新兴证据将p53的功能与ferroptosis的调节联系起来,ferroptosis是一种与癌症相关的独特形式的编程细胞死亡.
- 了解p53和铁亡之间的相互作用对于开发新型癌症疗法至关重要.
研究的目的:
- 阐明p53影响铁亡的分子途径和机制.
- 确定关键的上游和下游分子参与p53介导的铁灭.
- 探索在癌症治疗中准p53-ferroptosis轴的治疗潜力.
主要方法:
- 关于p53和ferroptosis的现有文献的全面审查和总结.
- 构建一个以p53为中心的网络,说明铁灭调节中的分子相互作用.
- 对目前针对野生类型p53 (wtp53) 功能和稳定性的药物开发策略的分析.
主要成果:
- 通过p53调节铁亡的途径和机制的详细映射.
- 在铁灭过程中与p53相互作用的分子网络的识别.
- 评估旨在维护或恢复WTP53活性的药物的进展和限制.
结论:
- p53在调节铁亡中起着重要作用,为癌症治疗提供了一条新的途径.
- 构建的p53-ferroptosis网络为理解治疗干预提供了一个框架.
- 需要进一步开发药物,才能充分利用wtp53在癌症治疗中的潜力.
相关概念视频
02:23Abnormal Proliferation
4.5K
Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.5K
01:23Negative Regulator Molecules
35.4K
Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
35.4K
02:37DNA Damage can Stall the Cell Cycle
9.2K
In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
9.2K
01:16Necrosis
4.5K
Necrosis is considered as an “accidental” or unexpected form of cell death that ends in cell lysis. The first noticeable mention of “necrosis” was in 1859 when Rudolf Virchow used this term to describe advanced tissue breakdown in his compilation titled “Cell Pathology”.
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
Morphological Manifestations of Necrosis
Necrotic cells show different types of morphological appearance depending on the type of tissue and infection. In coagulative necrosis, cells become...
4.5K
02:57Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
01:31The Intrinsic Apoptotic Pathway
6.6K
Internal cellular stress, such as cellular injury or hypoxia, triggers intrinsic apoptosis. The B-cell lymphoma 2 (Bcl-2) family of proteins are the primary regulators of the intrinsic apoptotic pathway. For example, during DNA damage, checkpoint proteins, such as Ataxia Telangiectasia Mutated (ATM protein) and Checkpoints Factor-2 (Chk2) proteins, are activated. These proteins phosphorylate p53 which further activates pro-apoptotic proteins, such as Bax, Bak, PUMA, and Noxa, and inhibits...
6.6K